The UK HALO Registry is a UK-wide registry of all patients being treated with HALO radiofrequency ablation (RFA) for dysplasia (pre-cancerous changes) and early cancer in Barrett’s oesophagus. HALO RFA is a safe and effective minimally-invasive therapy for these patients. It can be delivered through an endoscope, removing the need for surgery. It has recently been recommended by NICE. UCL Hospitals runs this registry for the whole country, and over 200 patients have already been recruited nationwide. We will shortly be publishing the results of this study, and interim results are favourable, showing a high early success rate. We are now collecting long-term outcome data so that we can be certain of the enduring benefits of this therapy.

The map shows all the sites participating in the UK HALO Registry.